Expertise in
2
conditions

Philip J. Robinson

50 Flemington Road, 
Parkville, VIC, AU 
Expertise in
2
conditions
50 Flemington Road, 
Parkville, VIC, AU 

Overview

Philip Robinson practices practicing medicine in Parkville, Australia.

Mr. Robinson is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Femoral Hernia, Camptocormism, Hernia, Thrombectomy, and Liver Transplant.

He is actively involved in clinical research, co-authoring 174 peer reviewed articles and participating in 8 clinical trials.

Gender

Male

Locations

50 Flemington Road, Parkville, VIC 3052, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

I-SPY COVID TRIAL: An Adaptive Platform Trial to Reduce Mortality and Ventilator Requirements for Critically Ill Patients
I-SPY COVID TRIAL: An Adaptive Platform Trial to Reduce Mortality and Ventilator Requirements for Critically Ill Patients
Enrollment Status: Active_not_recruiting
Publish Date: March 16, 2026
Intervention Type: Drug, Biological
Study Drugs: Remdesivir, Cenicriviroc, Icatibant, Pulmozyme, IC14, Celecoxib, Narsoplimab
Study Phase: Phase 2
ACTIV-6: COVID-19 Outpatient Randomized Trial to Evaluate Efficacy of Repurposed Medications
ACTIV-6: COVID-19 Outpatient Randomized Trial to Evaluate Efficacy of Repurposed Medications
Enrollment Status: Completed
Publish Date: November 17, 2025
Intervention Type: Other, Drug
Study Drugs: Ivermectin, Fluvoxamine, Fluticasone
Study Phase: Phase 3
RESOLUTION: A Double-blind, Randomized, Placebo-controlled, Phase II/III Study of the Efficacy and Safety of LAU-7b in the Treatment of Adult Hospitalized Patients With COVID-19 Disease
RESOLUTION: A Double-blind, Randomized, Placebo-controlled, Phase II/III Study of the Efficacy and Safety of LAU-7b in the Treatment of Adult Hospitalized Patients With COVID-19 Disease
Enrollment Status: Terminated
Publish Date: November 13, 2025
Intervention Type: Drug
Study Drug: Fenretinide
Study Phase: Phase 2/Phase 3
Phase 1b Open-Label Study of the Safety, Reactogenicity, and Immunogenicity of Subcutaneously and Orally Administered Prophylactic Vaccination With 2nd Generation (E1/E2B/E3-Deleted) Adenoviral COVID-19 in Normal Healthy Volunteers
Phase 1b Open-Label Study of the Safety, Reactogenicity, and Immunogenicity of Subcutaneously and Orally Administered Prophylactic Vaccination With 2nd Generation (E1/E2B/E3-Deleted) Adenoviral COVID-19 in Normal Healthy Volunteers
Enrollment Status: Terminated
Publish Date: October 15, 2024
Intervention Type: Drug, Biological
Study Drug: hAd5-S-Fusion+N-ETSD COVID-19 Vaccine
Study Phase: Phase 1
ISPY-P1.01: Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer: A Phase I/Ib Trial
ISPY-P1.01: Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer: A Phase I/Ib Trial
Enrollment Status: Withdrawn
Publish Date: November 18, 2023
Intervention Type: Drug
Study Phase: Phase 1
Adaptive Phase I-II Clinical Trial of Preventive Vaccine Consisting of Autologous Dendritic Cells Previously Incubated With S-protein From Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), in Subjects Negative for COVID-19 Infection and Anti-SARS-CoV-2 Antibodies
Adaptive Phase I-II Clinical Trial of Preventive Vaccine Consisting of Autologous Dendritic Cells Previously Incubated With S-protein From Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), in Subjects Negative for COVID-19 Infection and Anti-SARS-CoV-2 Antibodies
Enrollment Status: Withdrawn
Publish Date: May 03, 2023
Intervention Type: Biological
Study Phase: Phase 1/Phase 2
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 3 Study of Baricitinib in Patients With COVID-19 Infection
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 3 Study of Baricitinib in Patients With COVID-19 Infection
Enrollment Status: Completed
Publish Date: July 28, 2022
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Phase 3 Multi-centre Randomised Placebo-controlled Study of Azithromycin in the Primary Prevention of Radiologically-defined Bronchiectasis in Infants With Cystic Fibrosis.
A Phase 3 Multi-centre Randomised Placebo-controlled Study of Azithromycin in the Primary Prevention of Radiologically-defined Bronchiectasis in Infants With Cystic Fibrosis.
Enrollment Status: Completed
Publish Date: September 16, 2021
Intervention Type: Drug
Study Drug: Azithromycin
Study Phase: Phase 3
View 7 Less Clinical Trials

174 Total Publications

Elite cricket: a radiologic review of common musculoskeletal injuries in cricket athletes.
Elite cricket: a radiologic review of common musculoskeletal injuries in cricket athletes.
Journal: Skeletal radiology
Published: March 16, 2026

Frequently Asked Questions about Philip J. Robinson

Is Philip J. Robinson a top-rated expert for Femoral Hernia?

MediFind is an objective health platform that identifies experts based on real-world data. Philip J. Robinson is classified as an Distinguished expert for Femoral Hernia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Philip J. Robinson participate in research or clinical trials?

Yes. Philip J. Robinson has published 174 articles and abstracts on conditions like Femoral Hernia. You can view a list of Philip J. Robinson's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Robinson's expertise for a condition
ConditionClose
    View All 33 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile